130 related articles for article (PubMed ID: 2120996)
41. MR evaluation of laryngohypopharyngeal cancer: value of gadopentetate dimeglumine enhancement.
Sakai F; Sone S; Kiyono K; Maruyama A; Kawai T; Oguchi M; Naoto-Shikama ; Izuno I; Aoki J; Ueda H
AJNR Am J Neuroradiol; 1993; 14(5):1059-69. PubMed ID: 8237681
[TBL] [Abstract][Full Text] [Related]
42. Rheumatoid arthritis of the knee: value of gadopentetate dimeglumine-enhanced MR imaging.
Adam G; Dammer M; Bohndorf K; Christoph R; Fenke F; Günther RW
AJR Am J Roentgenol; 1991 Jan; 156(1):125-9. PubMed ID: 1898545
[TBL] [Abstract][Full Text] [Related]
43. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
44. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.
Chamberlain MC; Sandy AD; Press GA
Neurology; 1990 Mar; 40(3 Pt 1):435-8. PubMed ID: 2314584
[TBL] [Abstract][Full Text] [Related]
45. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
[TBL] [Abstract][Full Text] [Related]
46. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
47. Normal and abnormal pituitary glands: gadopentetate dimeglumine-enhanced MR imaging.
Sakamoto Y; Takahashi M; Korogi Y; Bussaka H; Ushio Y
Radiology; 1991 Feb; 178(2):441-5. PubMed ID: 1987606
[TBL] [Abstract][Full Text] [Related]
48. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
49. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
50. Gd-DTPA enhanced MR for detecting intracranial extension of sinonasal malignancies.
Van Tassel P; Lee YY
J Comput Assist Tomogr; 1991; 15(3):387-92. PubMed ID: 2026797
[TBL] [Abstract][Full Text] [Related]
51. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of gadolinium in MR brain imaging of HIV-infected patients.
Tuite M; Ketonen L; Kieburtz K; Handy B
AJNR Am J Neuroradiol; 1993; 14(1):257-63. PubMed ID: 8427101
[TBL] [Abstract][Full Text] [Related]
53. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
54. Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA.
Mirowitz SA
Abdom Imaging; 1993; 18(3):215-9. PubMed ID: 8508075
[TBL] [Abstract][Full Text] [Related]
55. Gadolinium-enhanced T1-weighted versus T2-weighted imaging of scrotal disorders: is there an indication for MR imaging?
Müller-Leisse C; Bohndorf K; Stargardt A; Sohn M; Neuerburg J; Adam G; Wein B; Urhahn R; Günther RW
J Magn Reson Imaging; 1994; 4(3):389-95. PubMed ID: 8061438
[TBL] [Abstract][Full Text] [Related]
56. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
Fernandez MP; Bernardino ME; Neylan JF; Olson RA
AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
[TBL] [Abstract][Full Text] [Related]
58. Gadolinium-DTPA enhanced MR imaging of septic dural sinus thrombosis.
Harris TM; Smith RR; Koch KJ
J Comput Assist Tomogr; 1989; 13(4):682-4. PubMed ID: 2745789
[TBL] [Abstract][Full Text] [Related]
59. MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients.
Kuhn MJ; Hammer GM; Swenson LC; Youssef HT; Gleason TJ
Comput Med Imaging Graph; 1994; 18(5):391-9. PubMed ID: 7954317
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.
Mirowitz SA; Brown JJ; Heiken JP
Radiology; 1993 Jan; 186(1):153-7. PubMed ID: 8416557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
